{"entity":{"type":"insider","cik":"0001857177","url":"/insider/0001857177","json_url":"/insider/0001857177.json","name":"Moat Ross","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":11,"n_filings":8,"first":"2024-09-04","last":"2026-04-13","span_basis":"filed_date"},"name_variants":[{"name":"Moat Ross","source":"filing","n_filings":8,"first_seen":"2024-09-04","last_seen":"2026-04-13"}],"transactions":[{"id":5900358,"accession":"0001857177-26-000006","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001857177-26-000006","line_url":"/filing/0001857177-26-000006#line-1","is_derivative":false,"issuer_cik":"0001730430","issuer_name":"Kiniksa Pharmaceuticals International, plc","issuer_ticker":"KNSA","issuer_name_source":null,"issuer_url":"/issuer/0001730430","owner_cik":"0001857177","owner_name":"Moat Ross","owner_display_name":"Moat Ross","owner_url":"/insider/0001857177","role":"Officer (CHIEF OPERATING OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF OPERATING OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF OPERATING OFFICER","security_title":"Class A Ordinary Share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1703.0,"shares_display":"1,703","price_per_share":46.69,"price_display":"46.69","price_state":"stated","total_value":79513.07,"total_display":"79,513.07","total_whole":"79,513","shares_owned_after":12029.0,"shares_owned_after_display":"12,029","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-04-09","filed_date":"2026-04-13","scope":"insider"},{"id":5792226,"accession":"0001857177-26-000004","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001857177-26-000004","line_url":"/filing/0001857177-26-000004#line-1","is_derivative":false,"issuer_cik":"0001730430","issuer_name":"Kiniksa Pharmaceuticals International, plc","issuer_ticker":"KNSA","issuer_name_source":null,"issuer_url":"/issuer/0001730430","owner_cik":"0001857177","owner_name":"Moat Ross","owner_display_name":"Moat Ross","owner_url":"/insider/0001857177","role":"Officer (CHIEF OPERATING OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF OPERATING OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF OPERATING OFFICER","security_title":"Class A Ordinary Share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2367.0,"shares_display":"2,367","price_per_share":48.58,"price_display":"48.58","price_state":"stated","total_value":114988.86,"total_display":"114,988.86","total_whole":"114,989","shares_owned_after":12029.0,"shares_owned_after_display":"12,029","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-04-06","filed_date":"2026-04-08","scope":"insider"},{"id":4862594,"accession":"0001415889-25-023874","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-25-023874","line_url":"/filing/0001415889-25-023874#line-1","is_derivative":false,"issuer_cik":"0001730430","issuer_name":"Kiniksa Pharmaceuticals International, plc","issuer_ticker":"KNSA","issuer_name_source":null,"issuer_url":"/issuer/0001730430","owner_cik":"0001857177","owner_name":"Moat Ross","owner_display_name":"Moat Ross","owner_url":"/insider/0001857177","role":"Officer (CHIEF CORP. & COMM. OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF CORP. & COMM. OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF CORP. & COMM. OFFICER","security_title":"Class A Ordinary Share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3523.0,"shares_display":"3,523","price_per_share":35.31,"price_display":"35.31","price_state":"stated","total_value":124397.13,"total_display":"124,397.13","total_whole":"124,397","shares_owned_after":9415.0,"shares_owned_after_display":"9,415","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-04","filed_date":"2025-09-08","scope":"insider"},{"id":5039690,"accession":"0001415889-25-015780","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-25-015780","line_url":"/filing/0001415889-25-015780#line-2","is_derivative":false,"issuer_cik":"0001730430","issuer_name":"Kiniksa Pharmaceuticals International, plc","issuer_ticker":"KNSA","issuer_name_source":null,"issuer_url":"/issuer/0001730430","owner_cik":"0001857177","owner_name":"Moat Ross","owner_display_name":"Moat Ross","owner_url":"/insider/0001857177","role":"Officer (CHIEF COMMERCIAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF COMMERCIAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF COMMERCIAL OFFICER","security_title":"Class A Ordinary Share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":27594.0,"shares_display":"27,594","price_per_share":29.02,"price_display":"29.02","price_state":"stated","total_value":800777.88,"total_display":"800,777.88","total_whole":"800,778","shares_owned_after":9415.0,"shares_owned_after_display":"9,415","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-06-03","filed_date":"2025-06-05","scope":"insider"},{"id":5080638,"accession":"0001415889-25-011992","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001415889-25-011992","line_url":"/filing/0001415889-25-011992#line-4","is_derivative":false,"issuer_cik":"0001730430","issuer_name":"Kiniksa Pharmaceuticals International, plc","issuer_ticker":"KNSA","issuer_name_source":null,"issuer_url":"/issuer/0001730430","owner_cik":"0001857177","owner_name":"Moat Ross","owner_display_name":"Moat Ross","owner_url":"/insider/0001857177","role":"Officer (CHIEF COMMERCIAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF COMMERCIAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF COMMERCIAL OFFICER","security_title":"Class A Ordinary Share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6272.0,"shares_display":"6,272","price_per_share":28.0,"price_display":"28.00","price_state":"stated","total_value":175616.0,"total_display":"175,616.00","total_whole":"175,616","shares_owned_after":9415.0,"shares_owned_after_display":"9,415","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-05-05","filed_date":"2025-05-05","scope":"insider"},{"id":5080629,"accession":"0001415889-25-011992","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-25-011992","line_url":"/filing/0001415889-25-011992#line-2","is_derivative":false,"issuer_cik":"0001730430","issuer_name":"Kiniksa Pharmaceuticals International, plc","issuer_ticker":"KNSA","issuer_name_source":null,"issuer_url":"/issuer/0001730430","owner_cik":"0001857177","owner_name":"Moat Ross","owner_display_name":"Moat Ross","owner_url":"/insider/0001857177","role":"Officer (CHIEF COMMERCIAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF COMMERCIAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF COMMERCIAL OFFICER","security_title":"Class A Ordinary Share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3850.0,"shares_display":"3,850","price_per_share":28.0,"price_display":"28.00","price_state":"stated","total_value":107800.0,"total_display":"107,800.00","total_whole":"107,800","shares_owned_after":9415.0,"shares_owned_after_display":"9,415","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-05-02","filed_date":"2025-05-05","scope":"insider"},{"id":4050951,"accession":"0001415889-25-011692","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001415889-25-011692","line_url":"/filing/0001415889-25-011692#line-10","is_derivative":false,"issuer_cik":"0001730430","issuer_name":"Kiniksa Pharmaceuticals International, plc","issuer_ticker":"KNSA","issuer_name_source":null,"issuer_url":"/issuer/0001730430","owner_cik":"0001857177","owner_name":"Moat Ross","owner_display_name":"Moat Ross","owner_url":"/insider/0001857177","role":"Officer (CHIEF COMMERCIAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF COMMERCIAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF COMMERCIAL OFFICER","security_title":"Class A Ordinary Share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":23234.0,"shares_display":"23,234","price_per_share":28.02,"price_display":"28.02","price_state":"stated","total_value":651016.68,"total_display":"651,016.68","total_whole":"651,017","shares_owned_after":9415.0,"shares_owned_after_display":"9,415","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-05-01","filed_date":"2025-05-01","scope":"insider"},{"id":4050944,"accession":"0001415889-25-011692","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001415889-25-011692","line_url":"/filing/0001415889-25-011692#line-6","is_derivative":false,"issuer_cik":"0001730430","issuer_name":"Kiniksa Pharmaceuticals International, plc","issuer_ticker":"KNSA","issuer_name_source":null,"issuer_url":"/issuer/0001730430","owner_cik":"0001857177","owner_name":"Moat Ross","owner_display_name":"Moat Ross","owner_url":"/insider/0001857177","role":"Officer (CHIEF COMMERCIAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF COMMERCIAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF COMMERCIAL OFFICER","security_title":"Class A Ordinary Share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":64035.0,"shares_display":"64,035","price_per_share":25.21,"price_display":"25.21","price_state":"stated","total_value":1614322.35,"total_display":"1,614,322.35","total_whole":"1,614,322","shares_owned_after":9415.0,"shares_owned_after_display":"9,415","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-04-29","filed_date":"2025-05-01","scope":"insider"},{"id":4050921,"accession":"0001415889-25-011209","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-25-011209","line_url":"/filing/0001415889-25-011209#line-1","is_derivative":false,"issuer_cik":"0001730430","issuer_name":"Kiniksa Pharmaceuticals International, plc","issuer_ticker":"KNSA","issuer_name_source":null,"issuer_url":"/issuer/0001730430","owner_cik":"0001857177","owner_name":"Moat Ross","owner_display_name":"Moat Ross","owner_url":"/insider/0001857177","role":"Officer (CHIEF COMMERCIAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF COMMERCIAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF COMMERCIAL OFFICER","security_title":"Class A Ordinary Share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18259.0,"shares_display":"18,259","price_per_share":20.29,"price_display":"20.29","price_state":"stated","total_value":370475.11,"total_display":"370,475.11","total_whole":"370,475","shares_owned_after":9415.0,"shares_owned_after_display":"9,415","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-04-21","filed_date":"2025-04-23","scope":"insider"},{"id":3237502,"accession":"0001415889-24-022854","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001415889-24-022854","line_url":"/filing/0001415889-24-022854","is_derivative":false,"issuer_cik":"0001730430","issuer_name":"Kiniksa Pharmaceuticals International, plc","issuer_ticker":"KNSA","issuer_name_source":null,"issuer_url":"/issuer/0001730430","owner_cik":"0001857177","owner_name":"Moat Ross","owner_display_name":"Moat Ross","owner_url":"/insider/0001857177","role":"Officer (CHIEF COMMERCIAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF COMMERCIAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF COMMERCIAL OFFICER","security_title":"Class A Ordinary Share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":68506.0,"shares_display":"68,506","price_per_share":26.117271479870375,"price_display":"26.12","price_state":"stated","total_value":1789189.8,"total_display":"1,789,189.80","total_whole":"1,789,190","shares_owned_after":22896.0,"shares_owned_after_display":"22,896","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-03","filed_date":"2024-09-04","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":11,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":11,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":11},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001730430","name":"Kiniksa Pharmaceuticals International, plc","url":"/issuer/0001730430","role":"Officer (CHIEF OPERATING OFFICER)","n_filings":8,"first_seen":"2024-09-04","last_seen":"2026-04-13"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001857177","retrieved_at":"2026-08-25T19:17:16+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}